Zoledronate Inhibits αvβ3 and αvβ5 Integrin Cell Surface Expression in Endothelial Cells

REFERENCES

• Bellahcène A., Bonjean K., Fohr B., Fedarko N. S., Robey F. A., Young M. F., Fisher L. W., Castronovo V. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circulation Research 2000; 86: 885–891
   PubMed Web of Science ®Google Scholar
• Bezzi M., Hasmim M., Bieler G., Dormond O., Ruegg C. Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. Journal of Biological Chemistry 2003; 278: 43603–43614
   PubMed Web of Science ®Google Scholar
• Boissier S., Magnetto S., Frappart L., Cuzin B., Ebetino F. H., Delmas P. D., Clezardin P. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Research 1997; 57: 3890–3894
   PubMed Web of Science ®Google Scholar
• Brooks P. C., Clark R. A., Cheresh D. A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 1994; 264: 569–571
   PubMed Web of Science ®Google Scholar
• Chaplet M., Detry C., Deroanne C., Fisher L. W., Castronovo V., Bellahcene A. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochemical Journal 2004; 384: 591–598
   PubMed Web of Science ®Google Scholar
• Cooper C. R., Chay C. H., Pienta K. J. The role of alpha(v)beta(3) in prostate cancer progression. Neoplasia 2002; 4: 191–194
   PubMed Web of Science ®Google Scholar
• Croucher P. I., de Hendrik R., Perry M. J., Hijzen A., Shipman C. M., Lippitt J., Green J., Van Marck E., Van Camp B., Vanderkerken K. Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival. Journal of Bone and Mineral Research 2003; 18: 482–492
   PubMed Web of Science ®Google Scholar
• Denoyelle C., Hong L., Vannier J. P., Soria J., Soria C. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. British Journal of Cancer 2003; 88: 1631–1640
   PubMed Web of Science ®Google Scholar
• Dimitrova Y., Dunoyer-Geindre S., Reber G., Mach F., Kruithof E. K., de Moerloose P. Effects of statins on adhesion molecule expression in endothelial cells. Journal of Thromobosis and Haemostasis 2003; 1: 2290–2299
   PubMed Web of Science ®Google Scholar
• Fleisch H. Bisphosphonates: Mechanisms of action. Endocrinological Reviews 1998; 19: 80–100
   PubMed Web of Science ®Google Scholar
• Fournier P., Boissier S., Filleur S., Guglielmi J., Cabon F., Colombel M., Clezardin P. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Research 2002; 62: 6538–6544
   PubMed Web of Science ®Google Scholar
• Gladson C. L., Cheresh D. A. Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. Journal of Clinical Investigation 1991; 88: 1924–1932
   PubMed Web of Science ®Google Scholar
• Gumbiner B. M. Cell adhesion: The molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345–357
   PubMed Web of Science ®Google Scholar
• Hall A., Nobes C. D. Rho GTPases: Molecular switches that control the organization and dynamics of the actin cytoskeleton. Philosophical Transactions of the Royal Society B: Biological Sciences 2000; 355: 965–970
   PubMed Web of Science ®Google Scholar
• Hoang M. V., Whelan M. C., Senger D. R. Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 1874–1879
   PubMed Web of Science ®Google Scholar
• Hotchin N. A., Hall A. The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. Journal of Cell Biology 1995; 131: 1857–1865
   PubMed Web of Science ®Google Scholar
• Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. Journal of Clinical Investigation 1973; 52: 2745–2756
   PubMed Web of Science ®Google Scholar
• Jockusch B. M., Bubeck P., Giehl K., Kroemker M., Moschner J., Rothkegel M., Rudiger M., Schluter K., Stanke G., Winkler J. The molecular architecture of focal adhesions. Annual Reviews of Cell and Developmental Biology 1995; 11: 379–416
   PubMed Web of Science ®Google Scholar
• Kaibuchi K., Kuroda S., Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annual Reviews of Biochemistry 1999; 68: 459–486
   PubMed Web of Science ®Google Scholar
• Liapis H., Flath A., Kitazawa S. Integrin alpha V beta 3 expression by bone-residing breast cancer metastases. Diagnostic Molecular Pathology 1996; 5: 127–135
   PubMed Web of Science ®Google Scholar
• Luckman S. P., Hughes D. E., Coxon F. P., Graham R., Russell G., Rogers M. J. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. Journal of Bone and Mineral Research 1998; 13: 581–589
   PubMed Web of Science ®Google Scholar
• Nobes C. D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81: 53–62
   PubMed Web of Science ®Google Scholar
• Pecheur I., Peyruchaud O., Serre C. M., Guglielmi J., Voland C., Bourre F., Margue C., Cohen-Solal M., Buffet A., Kieffer N., Clezardin P. Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB Journal 2002; 16: 1266–1268
   PubMed Web of Science ®Google Scholar
• Schwartz M. A., Shattil S. J. Signaling networks linking integrins and rho family GTPases. Trends in Biochemical Sciences 2000; 25: 388–391
   PubMed Web of Science ®Google Scholar
• Sharp J. A., Waltham M., Williams E. D., Henderson M. A., Thompson E. W. Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clinical and Experimental Metastasis 2004; 21: 19–29
   PubMed Web of Science ®Google Scholar
• Sloan E. K., Pouliot N., Stanley K. L., Chia J., Moseley J. M., Hards D. K., Anderson R. L. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Research 2006; 8: R20
   PubMed Web of Science ®Google Scholar
• van der Pluijm G., Vloedgraven H., Ivanov B., Robey F., Grzesik W., Gehron Robey P., Papapoulos S., Löwik C. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Research 1996a; 56: 1948–1955
   PubMed Web of Science ®Google Scholar
• van der Pluijm G., Vloedgraven H., van Beek E., van der Wee-Pals L., Lowik C., Papapoulos S. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. Journal of Clinical Investigations 1996b; 98: 698–705
   PubMed Web of Science ®Google Scholar
• Vincent L., Albanese P., Bompais H., Uzan G., Vannier J. P., Steg P. G., Soria J., Soria C. Insights in the molecular mechanisms of the anti-angiogenic effect of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Thrombosis and Haemostasis 2003; 89: 530–537
   PubMed Web of Science ®Google Scholar
• Weis M., Heeschen C., Glassford A. J., Cooke J. P. Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739–745
   PubMed Web of Science ®Google Scholar
• Wood J., Bonjean K., Ruetz S., Bellahcène A., Devy L., Foidart J. M., Castronovo V., Green J. R. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. Journal of Pharmacology and Experimental Therapeutics 2002; 302: 1055–1061
   PubMed Web of Science ®Google Scholar
• Yoshida Y., Kawata M., Katayama M., Horiuchi H., Kita Y., Takai Y. A geranylgeranyltransferase for rhoA p21 distinct from the farnesyltransferase for ras p21S. Biochememical and Biophysical Research Communications 1991; 175: 720–728
   PubMed Web of Science ®Google Scholar
• Zhang F. L., Casey P. J. Protein prenylation: Molecular mechanisms and functional consequences. Annual Reviews of Biochemistry 1996; 65: 241–269
   PubMed Web of Science ®Google Scholar